An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms INTEREST IN CD2
- Sponsors Ipsen
- 04 Dec 2017 Status changed from active, no longer recruiting to completed.
- 28 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Sep 2017.
- 28 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.